Brief: Archrock Q1 Adjusted EBITDA USD 221 Million Vs. IBES Estimate USD 216.6 Million
05/05/2026 21:15
May 05 (Reuters) - Archrock Q1 revenue USD 373.8 million vs. IBES estimate USD 379.5 million. Q1 net income USD 73.8 million
Recent news on Archrock
See all newsArchrock Q1 revenue rises but misses estimates, EBITDA beats
Brief: Archrock Q1 Adjusted EBITDA USD 221 Million Vs. IBES Estimate USD 216.6 Million
U.S. RESEARCH ROUNDUP- Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics
Gas compression services firm Archrock's Q4 revenue slightly misses estimates
Brief: Archrock Q4 Adjusted EBITDA USD 269.4 Million Vs. IBES Estimate USD 210.9 Million